Biotech Values

[jmkobers]

<<hypothetical best-case scenario>>

So, can we go ahead and presume that your MNTA price per share post of 80 dollars per share high end and 40 dollars per share low end for the single generic scenario(which is what we have now, don't give me any bull about that being based on the TEVA application being rejected or withdrawn as part of that projection)was similarly NOT an actual projection, but more of a "best case hypothetical" as well???

Great to get that clarified.